血栓调节蛋白经GPR15/Akt通路改善TGF-β1介导的慢性肾脏病
该研究构建了足细胞特异性人TGF-β1转基因小鼠模型,该小鼠出现进行性肾小球硬化、肾小管间质纤维化及肾功能衰竭。重组血栓调节蛋白治疗四周可显著抑制肾脏纤维化并改善器官功能,机制涉及与GPR15相互作用激活Akt通路、上调survivin等抗凋亡蛋白,从而抑制足细胞凋亡和间充质分化。
要点
- 重组血栓调节蛋白可抑制TGF-β1介导的肾脏纤维化并改善肾功能。
- 机制为结合GPR15激活Akt通路并上调survivin等抗凋亡蛋白。
- 体外及体内证据提示对足细胞凋亡和间充质分化有抑制作用。
核心结论
- 重组血栓调节蛋白可能对TGF-β1介导的慢性肾脏病及器官衰竭具有治疗潜力。
研究设计与样本
- 研究构建了足细胞特异性人TGF-β1转基因小鼠模型,用于评估重组血栓调节蛋白的治疗效果。
主要发现
- 转基因小鼠出现进行性肾小球硬化、肾小管间质纤维化及肾功能衰竭。
- 重组血栓调节蛋白治疗四周较未治疗转基因小鼠显著抑制肾脏纤维化并改善器官功能。
- 重组血栓调节蛋白与GPR15相互作用激活Akt通路,上调survivin等抗凋亡蛋白,抑制足细胞凋亡和间充质分化。
临床怎么用
- 提示重组血栓调节蛋白可能作为TGF-β1驱动慢性肾脏病纤维化的候选治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Kidney fibrosis is the common consequence of chronic kidney diseases that inexorably progresses to end-stage kidney disease with organ failure treatable only with replacement therapy. Since transforming growth factor-β1 is the main player in the pathogenesis of kidney fibrosis, we posed the hypothesis that recombinant thrombomodulin can ameliorate transforming growth factor-β1-mediated progressive kidney fibrosis and failure. To interrogate our hypothesis, we generated a novel glomerulus-specific human transforming growth factor-β1 transgenic mouse to evaluate the therapeutic effect of recombinant thrombomodulin. This transgenic mouse developed progressive glomerular sclerosis and tubulointerstitial fibrosis with kidney failure. Therapy with recombinant thrombomodulin for four weeks significantly inhibited kidney fibrosis and improved organ function compared to untreated transgenic mice. Treatment with recombinant thrombomodulin significantly inhibited apoptosis and mesenchymal differentiation of podocytes by interacting with the G-protein coupled receptor 15 to activate the Akt signaling pathway and to upregulate the expression of anti-apoptotic proteins including survivin. Thus, our study strongly suggests the potential therapeutic efficacy of recombinant thrombomodulin for the treatment of chronic kidney disease and subsequent organ failure.
引用
- Takeshita A, Yasuma T, Nishihama K, et al. Thrombomodulin ameliorates transforming growth factor-β1-mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway. Kidney Int. 2020. PMID: 33069430. doi:10.1016/j.kint.2020.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。